Polychlorinated biphenyls (PCBs) interact with drug metabolism in vivo
Archives of Toxicology, vol. 99, pp. 4423–4437
Abstract
Abstract Polychlorinated biphenyls (PCBs) are widespread environmental contaminants that interfere with xenobiotic metabolism, primarily by modulating cytochrome P450 (CYP) enzymes. However, their pharmacokinetic consequences in exposed individuals remain poorly defined. Here, we investigated the impact of PCB exposure on CYP enzyme activity using a combined clinical pharmacokinetic and in vitro mechanistic approach. Ten occupationally PCB-exposed individuals from the German HELPcB cohort and ten controls received a CYP phenotyping cocktail to assess enzyme function (Clinical Trial Registry: DRKS00028922). Plasma drug and metabolite concentrations were quantified to evaluate CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP2D6, and CYP3A activity, considering genetically defined metabolizer status. PCB118 exposure was significantly associated with reduced CYP1A2 activity (R2 = 0.155, t = − 2.115, p = 0.049, β = − 0.446), indicating a decrease in CYP1A2 activity with higher PCB118 levels. This was further supported by in vitro assays demonstrating dose-dependent inhibition. In addition, PCB74 exposure showed a trend toward increased CYP2C9 activity, suggesting a potential inductive effect. Mechanistic studies revealed that PCB118 acts as both an inhibitor and a substrate of CYP1A2, generating reactive arene oxide intermediates that may contribute to mechanism-based inhibition. These findings challenge the traditional view of PCBs as merely chronic toxicants, showing that they can acutely alter drug metabolism and potentially impact drug efficacy and safety. Given the widespread presence of PCBs and other persistent organic pollutants, these results highlight the need to integrate environmental toxicant exposure into pharmacokinetic models to optimize drug therapy and minimize adverse effects.
Authors 16
-
RWTH Aachen University · Universitätsklinikum Aachen
Affiliation as printed
Institute of Clinical Pharmacology, University Hospital of RWTH, 52074, Aachen, Germany
-
Jens Rengelshausen Aachen Medical Faculty Institute for Occupational, Social and Environmental Medicine
Affiliation as printed
Institute for Occupational, Social and Environmental Medicine, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany
-
Affiliation as printed
Institute for Occupational, Social and Environmental Medicine, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany
-
Affiliation as printed
Institute for Occupational, Social and Environmental Medicine, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany
-
Affiliation as printed
Institute for Occupational, Social and Environmental Medicine, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany
-
Thomas Schettgen Aachen Medical Faculty Institute for Occupational, Social and Environmental Medicine
Affiliation as printed
Institute for Occupational, Social and Environmental Medicine, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany
-
Affiliation as printed
Institute for Occupational, Social and Environmental Medicine, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany
-
Affiliation as printed
Institute for Occupational, Social and Environmental Medicine, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany
-
University of Tübingen · Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
Affiliation as printed
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart and University of Tuebingen, Tuebingen, Germany
-
RWTH Aachen University · Universitätsklinikum Aachen
Affiliation as printed
Institute of Clinical Pharmacology, University Hospital of RWTH, 52074, Aachen, Germany
-
RWTH Aachen University · Universitätsklinikum Aachen
Affiliation as printed
Institute of Clinical Pharmacology, University Hospital of RWTH, 52074, Aachen, Germany
-
University of Tübingen · Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
Affiliation as printed
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart and University of Tuebingen, Tuebingen, Germany
-
University of Tübingen · Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
Affiliation as printed
Departments of Clinical Pharmacology, and Pharmacy and Biochemistry, University of Tuebingen, Tuebingen, Germany
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart and University of Tuebingen, Tuebingen, Germany
-
RWTH Aachen University · Universitätsklinikum Aachen · University Hospital Heidelberg
Affiliation as printed
Department of Clinical Pharmacology and Pharmacoepidemiology, University Hospital Heidelberg, Heidelberg, Germany
Institute of Clinical Pharmacology, University Hospital of RWTH, 52074, Aachen, Germany
-
Affiliation as printed
Institute for Occupational, Social and Environmental Medicine, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany
-
Patrick Ziegler corresponding Aachen Medical Faculty Institute for Occupational, Social and Environmental Medicine
Affiliation as printed
Institute for Occupational, Social and Environmental Medicine, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany. pziegler@ukaachen.de
Cited by 4 stored of 4
4 results
No patents citing this paper on Lens.org (checked 2026-10-06).
References 40
-
W2005156172details pending0citations
-
W1983575656details pending0citations
-
W2906450567details pending0citations
-
W3083556913details pending0citations
-
W4380051363details pending0citations
-
W1964929421details pending0citations
-
W1987902467details pending0citations
-
W2019641265details pending0citations
-
W2024599981details pending0citations
-
W2027717019details pending0citations
-
W2031092738details pending0citations